A Norwegian Observational Trial Evaluating the Treatment of Advanced Renal Cell Cancer Patients Under Treatment of Afinitor

Clinical trial NCT01390519 · COMPLETED

Trial details

NCT number: NCT01390519
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Renal Cell Carcinoma (mRCC)

Start date: 2011-06-01
Primary completion: 2015-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.